Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jul 2023 for RVL Pharmaceuticals plc.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gregory L. Cowan: trading record in brief
Gregory L. Cowan (board member) discloses dealings in 2 companies, chiefly RVL Pharmaceuticals plc and VWR Corp. Between 28 February 2017 and 5 July 2023, the trades on record add up to 11 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 11 July 2023, reports a share grant in RVL Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory L. Cowan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
40,000 shares0Ordinary SharesSEC:0001104659-23-080117:0
5,506 shares@ US$3.3125.6% of flowOrdinary SharesSEC:0001104659-21-112916:0
18,584 shares@ US$2.8974.4% of flowOrdinary SharesSEC:0001104659-21-084087:0
3 of 3 declarations
